{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:53:05Z","timestamp":1779886385744,"version":"3.53.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T00:00:00Z","timestamp":1506643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T00:00:00Z","timestamp":1506643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Synapses are an early pathological target in many neurodegenerative diseases ranging from well-known adult onset conditions such as Alzheimer and Parkinson disease to neurodegenerative conditions of childhood such as spinal muscular atrophy (SMA) and neuronal ceroid lipofuscinosis (NCLs). However, the reasons why synapses are particularly vulnerable to such a broad range of neurodegeneration inducing stimuli remains unknown. To identify molecular modulators of synaptic stability and degeneration, we have used the <jats:italic>Cln3<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mouse model of a juvenile form of NCL. We profiled and compared the molecular composition of anatomically-distinct, differentially-affected pre-synaptic populations from the <jats:italic>Cln3<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mouse brain using proteomics followed by bioinformatic analyses. Identified protein candidates were then tested using a <jats:italic>Drosophila<\/jats:italic> CLN3 model to study their ability to modify the CLN3-neurodegenerative phenotype <jats:italic>in vivo<\/jats:italic>. We identified differential perturbations in a range of molecular cascades correlating with synaptic vulnerability, including valine catabolism and rho signalling pathways. Genetic and pharmacological targeting of key \u2018hub\u2019 proteins in such pathways was sufficient to modulate phenotypic presentation in a <jats:italic>Drosophila<\/jats:italic> CLN3 model. We propose that such a workflow provides a target rich method for the identification of novel disease regulators which could be applicable to the study of other conditions where appropriate models exist.<\/jats:p>","DOI":"10.1038\/s41598-017-12603-0","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T09:56:43Z","timestamp":1506333403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Proteomic mapping of differentially vulnerable pre-synaptic populations identifies regulators of neuronal stability in vivo"],"prefix":"10.1038","volume":"7","author":[{"given":"Maica","family":"Llavero Hurtado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi R.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M. S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha L.","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0306-5577","authenticated-orcid":false,"given":"Thomas H.","family":"Gillingwater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppa","family":"Pennetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Wishart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,29]]},"reference":[{"key":"12603_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/01.jnen.0000228202.35163.c4","volume":"65","author":"TM Wishart","year":"2006","unstructured":"Wishart, T. M., Parson, S. H. & Gillingwater, T. H. Synaptic vulnerability in neurodegenerative disease. J Neuropathol Exp Neurol. \n                           65, 733\u2013739 (2006).","journal-title":"J Neuropathol Exp Neurol."},{"key":"12603_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002936","volume":"8","author":"TM Wishart","year":"2012","unstructured":"Wishart, T. M. et al. Combining comparative proteomics and molecular genetics uncovers regulators of synaptic and axonal stability and degeneration in vivo. PLoS genetics \n                           8, e1002936, https:\/\/doi.org\/10.1371\/journal.pgen.1002936 (2012).","journal-title":"PLoS genetics"},{"key":"12603_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ana.410270502","volume":"27","author":"ST DeKosky","year":"1990","unstructured":"DeKosky, S. T. & Scheff, S. W. Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity. Ann Neurol. \n                           27, 457\u2013464 (1990).","journal-title":"Ann Neurol."},{"key":"12603_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe, D. J. Alzheimer\u2019s disease is a synaptic failure. Science \n                           298, 789\u2013791 (2002).","journal-title":"Science"},{"key":"12603_CR5","doi-asserted-by":"crossref","unstructured":"Meek P. D, M. K., Schumock GT. Economic considerations in Alzheimer\u2019s disease. Pharmacotherapy. (2 Pt 2): 68\u201373; discussion 79-82 (1998).","DOI":"10.1002\/j.1875-9114.1998.tb03880.x"},{"key":"12603_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","volume":"55","author":"LS Forno","year":"1996","unstructured":"Forno, L. S. Neuropathology of Parkinson disease. J. Neuropathol. Exp. Neurol \n                           55, 259\u2013272 (1996).","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"12603_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","volume":"185","author":"LR Fischer","year":"2004","unstructured":"Fischer, L. R., Culver, D. G., Tennant, P., Davis, A. A. & Wang, M. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol \n                           185, 232\u2013240 (2004).","journal-title":"Exp Neurol"},{"key":"12603_CR8","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/hmg\/ddm367","volume":"17","author":"LM Murray","year":"2008","unstructured":"Murray, L. M., Comley, L. H., Thomson, D., Parkinson, N. & Talbot, K. Selective vulnerability of motor neurons and dissociation of pre- and post- synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Human molecular genetics \n                           17, 949\u2013962 (2008).","journal-title":"Human molecular genetics"},{"key":"12603_CR9","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","volume":"20","author":"KP Murphy","year":"2000","unstructured":"Murphy, K. P., Carter, R. J., Lione, L. A., Mangiarini, L. & Mahal, A. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic or exon 1 of the human Huntington\u2019s disease mutation. J Neurosci \n                           20, 5115\u20135123 (2000).","journal-title":"J Neurosci"},{"key":"12603_CR10","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1046\/j.1460-9568.2003.02662.x","volume":"17","author":"C Cunningham","year":"2003","unstructured":"Cunningham, C., Deacon, R., Wells, H., Boche, D. & Waters, S. Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur J Neurosci \n                           17, 2147\u20132155 (2003).","journal-title":"Eur J Neurosci"},{"key":"12603_CR11","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1523\/JNEUROSCI.6065-09.2010","volume":"30","author":"EM Perkins","year":"2010","unstructured":"Perkins, E. M., Clarkson, Y. L., Sabatier, N., Longhurst, D. M. & Millward, C. P. Loss of beta-III spectrin leads to Purkinje cell dysfunction recapitulating the behavior and neuropathology of spinocerebellar ataxia type 5 in humans. J Neurosci \n                           30, 4857\u20134867 (2010).","journal-title":"J Neurosci"},{"key":"12603_CR12","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1093\/hmg\/ddp355","volume":"18","author":"C Kielar","year":"2009","unstructured":"Kielar, C. et al. Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease. Human molecular genetics \n                           18, 4066\u20134080, https:\/\/doi.org\/10.1093\/hmg\/ddp355 (2009).","journal-title":"Human molecular genetics"},{"key":"12603_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.nbd.2005.03.012","volume":"20","author":"T Virmani","year":"2005","unstructured":"Virmani, T., Gupta, P., Liu, X., Kavalali, E. T. & Hofmann, S. L. Progressively reduced synaptic vesicle pool size in cultured neurons derived from neuronal ceroid lipofuscinosis-1 knockout mice. Neurobiol. Dis \n                           20, 314\u2013323 (2005).","journal-title":"Neurobiol. Dis"},{"key":"12603_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/nen.0b013e31815f3899","volume":"67","author":"S Partanen","year":"2008","unstructured":"Partanen, S. et al. Synaptic changes in the thalamocortical system of cathepsin D-deficient mice: a model of human congenital neuronal ceroid-lipofuscinosis. J. Neuropathol. Exp. Neurol. \n                           67, 16\u201329 (2008).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"12603_CR15","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1097\/NEN.0b013e318238fc28","volume":"70","author":"S Koch","year":"2011","unstructured":"Koch, S. et al. Morphologic and functional correlates of synaptic pathology in the cathepsin D knockout mouse model of congenital neuronal ceroid lipofuscinosis. Neuropathol Exp Neurol \n                           70, 1089\u20131096 (2011).","journal-title":"Neuropathol Exp Neurol"},{"key":"12603_CR16","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1042\/BST0381448","volume":"38","author":"JD Cooper","year":"2010","unstructured":"Cooper, J. D. The neuronal ceroid lipofuscinoses: the same, but different? Biochemical Society transactions \n                           38, 1448\u20131452, https:\/\/doi.org\/10.1042\/BST0381448 (2010).","journal-title":"Biochemical Society transactions"},{"key":"12603_CR17","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1172\/JCI71318","volume":"124","author":"TM Wishart","year":"2014","unstructured":"Wishart, T. M. et al. Dysregulation of ubiquitin homeostasis and beta-catenin signaling promote spinal muscular atrophy. The Journal of clinical investigation \n                           124, 1821\u20131834, https:\/\/doi.org\/10.1172\/JCI71318 (2014).","journal-title":"The Journal of clinical investigation"},{"key":"12603_CR18","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.87908","volume":"1","author":"RA Powis","year":"2016","unstructured":"Powis, R. A. et al. Systemic restoration of UBA1 ameliorates disease in spinal muscular atrophy. JCI insight \n                           1, e87908, https:\/\/doi.org\/10.1172\/jci.insight.87908 (2016).","journal-title":"JCI insight"},{"key":"12603_CR19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1177\/088307389501000602","volume":"10","author":"HH Goebel","year":"1995","unstructured":"Goebel, H. H. The neuronal ceroid-lipofuscinoses. J. Child. Neurol \n                           10, 424\u2013437 (1995).","journal-title":"J. Child. Neurol"},{"key":"12603_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1055\/s-2007-973654","volume":"28","author":"P Uvebrant","year":"1997","unstructured":"Uvebrant, P. & Hagberg, B. Neuronal ceroid lipofuscinoses in Scandinavia. Epidemiology and clinical pictures. Neuropediatrics \n                           28, 6\u20138 (1997).","journal-title":"Neuropediatrics"},{"key":"12603_CR21","doi-asserted-by":"crossref","unstructured":"Mole, S., Williams, R. & Goebel, H. H. The neuronal ceroid lipofuscinoses (Batten disease). 2nd ed. Oxford: Oxford University Press (2011).","DOI":"10.1093\/med\/9780199590018.001.0001"},{"key":"12603_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/00019052-200304000-00001","volume":"16","author":"JD Cooper","year":"2003","unstructured":"Cooper, J. D. Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis. Current opinion in neurology \n                           16, 121\u2013128, https:\/\/doi.org\/10.1097\/01.wco.0000063762.15877.9b (2003).","journal-title":"Current opinion in neurology"},{"key":"12603_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10048-005-0218-3","volume":"6","author":"SE Mole","year":"2005","unstructured":"Mole, S. E., Williams, R. E. & Goebel, H. H. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics \n                           6, 107\u2013126 (2005).","journal-title":"Neurogenetics"},{"key":"12603_CR24","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.bbadis.2006.08.002","volume":"1762","author":"JD Cooper","year":"2006","unstructured":"Cooper, J. D., Russell, C. & Mitchison, H. M. Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis. Biochimica et biophysica acta \n                           1762, 873\u2013889, https:\/\/doi.org\/10.1016\/j.bbadis.2006.08.002 (2006).","journal-title":"Biochimica et biophysica acta"},{"key":"12603_CR25","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.bbadis.2013.01.009","volume":"1832","author":"M Bond","year":"2013","unstructured":"Bond, M., Holthaus, S. M., Tammen, I., Tear, G. & Russell, C. Use of model organisms for the study of neuronal ceroid lipofuscinosis. Biochimica et biophysica acta \n                           1832, 1842\u20131865, https:\/\/doi.org\/10.1016\/j.bbadis.2013.01.009 (2013).","journal-title":"Biochimica et biophysica acta"},{"key":"12603_CR26","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/0092-8674(95)90274-0","volume":"82","author":"The International Batten Disease Consortium","year":"1995","unstructured":"The International Batten Disease Consortium. Isolation of a novel gene underlying Batten disease, CLN3. Cell \n                           82, 949\u2013957 (1995).","journal-title":"Cell"},{"key":"12603_CR27","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1006\/mgme.1999.2819","volume":"66","author":"DA Pearce","year":"1999","unstructured":"Pearce, D. A., Nosel, S. A. & Sherman, F. Studies of pH regulation by Btn1p, the yeast homolog of human Cln3p. Mol Genet Metab. \n                           66, 320\u2013323 (1999).","journal-title":"Mol Genet Metab."},{"key":"12603_CR28","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1093\/hmg\/ddh321","volume":"13","author":"K Luiro","year":"2004","unstructured":"Luiro, K. et al. Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway. Human molecular genetics \n                           13, 3017\u20133027, https:\/\/doi.org\/10.1093\/hmg\/ddh321 (2004).","journal-title":"Human molecular genetics"},{"key":"12603_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.molmed.2012.11.002","volume":"19","author":"G Hamilton","year":"2013","unstructured":"Hamilton, G. & Gillingwater, T. H. Spinal muscular atrophy: going beyond the motor neuron. Trends Mol Med. \n                           19, 40\u201350 (2013).","journal-title":"Trends Mol Med."},{"key":"12603_CR30","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/ana.410420517","volume":"42","author":"I J\u00e4rvel\u00e4","year":"1997","unstructured":"J\u00e4rvel\u00e4, I. et al. Clinical and magnetic resonance imaging findings in Batten disease: analysis of the major mutation (1.02-kb deletion). Ann Neurol. \n                           42, 799\u2013802 (1997).","journal-title":"Ann Neurol."},{"key":"12603_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1006\/nbdi.1999.0267","volume":"6","author":"HM Mitchison","year":"1999","unstructured":"Mitchison, H. M., Bernard, D. J. & Greene, N. Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium. Neurobiol Dis. \n                           6, 321\u2013334 (1999).","journal-title":"Neurobiol Dis."},{"key":"12603_CR32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.brainres.2004.07.030","volume":"1023","author":"CC Pontikis","year":"2004","unstructured":"Pontikis, C. C. et al. Late onset neurodegeneration in the Cln3\u2212\/\u2212 mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation. Brain research \n                           1023, 231\u2013242, https:\/\/doi.org\/10.1016\/j.brainres.2004.07.030 (2004).","journal-title":"Brain research"},{"key":"12603_CR33","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1177\/0883073813494479","volume":"28","author":"TG Kuhl","year":"2013","unstructured":"Kuhl, T. G., Dihanich, S., Wong, A. M. & Cooper, J. D. Regional brain atrophy in mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal perspective. Journal of child neurology \n                           28, 1117\u20131122, https:\/\/doi.org\/10.1177\/0883073813494479 (2013).","journal-title":"Journal of child neurology"},{"key":"12603_CR34","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.nbd.2005.05.018","volume":"20","author":"CC Pontikis","year":"2005","unstructured":"Pontikis, C. C., Cotman, S. L., MacDonald, M. E. & Cooper, J. D. Thalamocortical neuron loss and localized astrocytosis in the Cln3Deltaex7\/8 knock-in mouse model of Batten disease. Neurobiol Dis. \n                           20, 823\u2013836 (2005).","journal-title":"Neurobiol Dis."},{"key":"12603_CR35","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.nbd.2006.09.001","volume":"25","author":"C Kielar","year":"2007","unstructured":"Kielar, C. et al. Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis. Neurobiology of disease \n                           25, 150\u2013162, https:\/\/doi.org\/10.1016\/j.nbd.2006.09.001 (2007).","journal-title":"Neurobiology of disease"},{"key":"12603_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1053\/ejpn.2000.0454","volume":"5","author":"P Santavuori","year":"2001","unstructured":"Santavuori, P., Vanhanen, S. L. & Autti, T. Clinical and neuroradiological diagnostic aspects of neuronal ceroid lipofuscinoses disorders. Eur J Paediatr Neurol. \n                           5, 157\u2013161 (2001).","journal-title":"Eur J Paediatr Neurol."},{"key":"12603_CR37","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1468-1331.2007.01692.x","volume":"14","author":"T Autti","year":"2007","unstructured":"Autti, T. et al. Thalami and corona radiata in juvenile NCL (CLN3): a voxel-based morphometric study. Eur J Neurol. \n                           14, 447\u2013450 (2007).","journal-title":"Eur J Neurol."},{"key":"12603_CR38","doi-asserted-by":"publisher","first-page":"618","DOI":"10.2174\/138920210793360943","volume":"11","author":"X Wang","year":"2010","unstructured":"Wang, X., Michaelis, M. & Michaelis, E. Functional genomics of brain aging and Alzheimers disease: focus on selective neuronal vulnerability. Curr Genomics \n                           11, 618\u2013633 (2010).","journal-title":"Curr Genomics"},{"key":"12603_CR39","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nn.3606","volume":"17","author":"U Khan","year":"2014","unstructured":"Khan, U. et al. Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer\u2019s disease. Nat Neurosci. \n                           17, 304\u2013311 (2014).","journal-title":"Nat Neurosci."},{"key":"12603_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H Braak","year":"1995","unstructured":"Braak, H. & Braak, E. Staging of Alzheimer\u2019s disease-related neurofibrillary changes. Neurobiol Aging \n                           16, 271\u2013278 (1995).","journal-title":"Neurobiol Aging"},{"key":"12603_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier, D. J., Obeso, J. A. & Halliday, G. M. Selective neuronal vulnerability in Parkinson disease. Nature reviews. Neuroscience \n                           18, 101\u2013113, https:\/\/doi.org\/10.1038\/nrn.2016.178 (2017).","journal-title":"Nature reviews. Neuroscience"},{"key":"12603_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.nbd.2012.11.014","volume":"52","author":"NM Lewandowski","year":"2013","unstructured":"Lewandowski, N. M. et al. Regional vulnerability in Huntington\u2019s disease: fMRI-guided molecular analysis in patients and a mouse model of disease. Neurobiology of disease \n                           52, 84\u201393, https:\/\/doi.org\/10.1016\/j.nbd.2012.11.014 (2013).","journal-title":"Neurobiology of disease"},{"key":"12603_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.0305-1846.2001.00299.x","volume":"27","author":"KA Sieradzan","year":"2001","unstructured":"Sieradzan, K. A. & Mann, D. M. A. The selective vulnerability of nerve cells in Huntington\u2019s disease. Neuropathology and applied neurobiology \n                           27, 1\u201321 (2001).","journal-title":"Neuropathology and applied neurobiology"},{"key":"12603_CR44","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/nprot.2009.177","volume":"4","author":"A Theocharidis","year":"2009","unstructured":"Theocharidis, A., van Dongen, S., Enright, A. J. & Freeman, T. C. Network visualization and analysis of gene expression data using BioLayout Express(3D). Nat. Protoc. \n                           4, 1535\u20131550 (2009).","journal-title":"Nat. Protoc."},{"key":"12603_CR45","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1093\/nar\/30.7.1575","volume":"30","author":"AJ Enright","year":"2002","unstructured":"Enright, A. J., Van Dongen, S. & Ouzounis, C. A. An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res. \n                           30, 1575\u20131584 (2002).","journal-title":"Nucleic Acids Res."},{"key":"12603_CR46","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/nan.12014","volume":"39","author":"TH Gillingwater","year":"2013","unstructured":"Gillingwater, T. H. & Wishart, T. M. Mechanisms underlying synaptic vulnerability and degeneration in neurodegenerative disease. Neuropathology and applied neurobiology \n                           39, 320\u2013334, https:\/\/doi.org\/10.1111\/nan.12014 (2013).","journal-title":"Neuropathology and applied neurobiology"},{"key":"12603_CR47","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1002\/jnr.21015","volume":"84","author":"K Luiro","year":"2006","unstructured":"Luiro, K. et al. Batten disease (JNCL) is linked to disturbances in mitochondrial, cytoskeletal, and synaptic compartments. Journal of neuroscience research \n                           84, 1124\u20131138, https:\/\/doi.org\/10.1002\/jnr.21015 (2006).","journal-title":"Journal of neuroscience research"},{"key":"12603_CR48","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.neuint.2013.03.007","volume":"62","author":"S Kang","year":"2013","unstructured":"Kang, S., Seo, J. H., Heo, T. H. & Kim, S. J. Batten disease is linked to altered expression of mitochondria-related metabolic molecules. Neurochem Int \n                           62, 931\u2013935 (2013).","journal-title":"Neurochem Int"},{"key":"12603_CR49","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ceca.2011.08.004","volume":"50","author":"J Kolikova","year":"2011","unstructured":"Kolikova, J., Afzalov, R., Surin, A., Lehesjoki, A. E. & Khiroug, L. Deficient mitochondrial Ca(2+) buffering in the Cln8(mnd) mouse model of neuronal ceroid lipofuscinosis. Cell Calcium \n                           50, 491\u2013501 (2011).","journal-title":"Cell Calcium"},{"key":"12603_CR50","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0197-0186(01)00128-0","volume":"40","author":"RD Jolly","year":"2002","unstructured":"Jolly, R. D., Brown, S., Das, A. M. & Walkley, S. U. Mitochondrial dysfunction in the neuronal ceroid-lipofuscinoses (Batten disease). Neurochemistry International \n                           40, 565\u2013557 (2002).","journal-title":"Neurochemistry International"},{"key":"12603_CR51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1086\/510725","volume":"80","author":"FJ Loupatty","year":"2007","unstructured":"Loupatty, F. J. et al. Mutations in the gene encoding 3-hydroxyisobutyryl-CoA hydrolase results in progressive infantile neurodegeneration. American journal of human genetics \n                           80, 195\u2013199, https:\/\/doi.org\/10.1086\/510725 (2007).","journal-title":"American journal of human genetics"},{"key":"12603_CR52","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1542\/peds.70.4.532","volume":"70","author":"GK Brown","year":"1982","unstructured":"Brown, G. K. et al. b- hydroxyisobutyryl coenzyme A deacylase deficiency: a defect in valine metabolism associated with physical malformations. Pediatrics \n                           70, 532\u2013538 (1982).","journal-title":"Pediatrics"},{"key":"12603_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-188","volume":"8","author":"S Ferdinandusse","year":"2013","unstructured":"Ferdinandusse, S. et al. HIBCH mutations can cause Leigh-like disease with combined deficiency of multiple mitochondrial respiratory chain enzymes and pyruvate dehydrogenase. Orphanet J Rare Dis. \n                           8, 188 (2013).","journal-title":"Orphanet J Rare Dis."},{"key":"12603_CR54","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1006\/bbrc.1994.1302","volume":"199","author":"T Kamijo","year":"1994","unstructured":"Kamijo, T., Aoyama, T., Komiyama, A. & Hashimoto, T. Structural analysis of cDNAs for subunits of human mitochondrial fatty acid \u03b2-oxidation trifunctional protein. Biochem. Biophys. Res. Commun. \n                           199, 818\u2013825 (1994).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"12603_CR55","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1172\/JCI12590","volume":"107","author":"JA Ibdah","year":"2001","unstructured":"Ibdah, J. A. et al. Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. J Clin Invest. \n                           107, 1403\u20131409 (2001).","journal-title":"J Clin Invest."},{"key":"12603_CR56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ymgme.2012.02.015","volume":"106","author":"AL Fletcher","year":"2012","unstructured":"Fletcher, A. L., Pennesi, M. E., Harding, C. O., Weleber, R. G. & Gillingham, M. B. Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies. Mol Genet Metab. \n                           106, 18\u201324 (2012).","journal-title":"Mol Genet Metab."},{"key":"12603_CR57","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/hmg\/ddn396","volume":"18","author":"RI Tuxworth","year":"2009","unstructured":"Tuxworth, R. I., Vivancos, V., O\u2019Hare, M. B. & Tear, G. Interactions between the juvenile Batten disease gene, CLN3, and the Notch and JNK signalling pathways. Human molecular genetics \n                           18, 667\u2013678, https:\/\/doi.org\/10.1093\/hmg\/ddn396 (2009).","journal-title":"Human molecular genetics"},{"key":"12603_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-7-27","volume":"7","author":"Z-S Xu","year":"2012","unstructured":"Xu, Z.-S. Does a loss of TDP-43 function cause neurodegeneration? Molecular Neurodegeneration \n                           7, 27, https:\/\/doi.org\/10.1186\/1750-1326-7-27 (2012).","journal-title":"Molecular Neurodegeneration"},{"key":"12603_CR59","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nrm1128","volume":"4","author":"K Riento","year":"2003","unstructured":"Riento, K. & Ridley, A. J. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol \n                           4, 446\u2013456 (2003).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"12603_CR60","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neuropharm.2008.07.031","volume":"56","author":"Z Zhou","year":"2009","unstructured":"Zhou, Z., Meng, Y., Asrar, S., Todorovski, Z. & Jia, Z. A critical role of Rho-kinase ROCK2 in the regulation of spine and synaptic function. Neuropharmacology \n                           56, 81\u201389, https:\/\/doi.org\/10.1016\/j.neuropharm.2008.07.031 (2009).","journal-title":"Neuropharmacology"},{"key":"12603_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008287","volume":"4","author":"C Deyts","year":"2009","unstructured":"Deyts, C. et al. Dopamine D2 receptor stimulation potentiates PolyQ-Huntingtin-induced mouse striatal neuron dysfunctions via Rho\/ROCK-II activation. PLoS One \n                           4, e8287, https:\/\/doi.org\/10.1371\/journal.pone.0008287 (2009).","journal-title":"PLoS One"},{"key":"12603_CR62","doi-asserted-by":"publisher","first-page":"6117","DOI":"10.1074\/jbc.M110.167239","volume":"286","author":"JH Herskowitz","year":"2011","unstructured":"Herskowitz, J. H. et al. Rho kinase II phosphorylation of the lipoprotein receptor LR11\/SORLA alters amyloid-beta production. The Journal of biological chemistry \n                           286, 6117\u20136127, https:\/\/doi.org\/10.1074\/jbc.M110.167239 (2011).","journal-title":"The Journal of biological chemistry"},{"key":"12603_CR63","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1126\/science.1090154","volume":"302","author":"Y Zhou","year":"2003","unstructured":"Zhou, Y. et al. Nonsteroidal Anti-Inflammatory Drugs Can Lower Amyloidogenic AB42 by Inhibiting Rho. Science \n                           302, 1215\u20131217 (2003).","journal-title":"Science"},{"key":"12603_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030917","volume":"7","author":"S Blaise","year":"2012","unstructured":"Blaise, S. et al. In vivo evidence that TRAF4 is required for central nervous system myelin homeostasis. PLoS One \n                           7, e30917, https:\/\/doi.org\/10.1371\/journal.pone.0030917 (2012).","journal-title":"PLoS One"},{"key":"12603_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-10-24","volume":"10","author":"M Bowerman","year":"2012","unstructured":"Bowerman, M., Murray, L. M., Boyer, J. G., Anderson, C. L. & Kothary, R. Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy. BMC medicine \n                           10, 24, https:\/\/doi.org\/10.1186\/1741-7015-10-24 (2012).","journal-title":"BMC medicine"},{"key":"12603_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2014.00271","volume":"8","author":"E Coque","year":"2014","unstructured":"Coque, E., Raoul, C. & Bowerman, M. ROCK inhibition as a therapy for spinal muscular atrophy: understanding the repercussions on multiple cellular targets. Frontiers in neuroscience \n                           8, 271, https:\/\/doi.org\/10.3389\/fnins.2014.00271 (2014).","journal-title":"Frontiers in neuroscience"},{"key":"12603_CR67","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3171\/jns.1986.65.1.0080","volume":"65","author":"M Takayasu","year":"1986","unstructured":"Takayasu, M. et al. The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs. Journal of Neurosurgery \n                           65, 80\u201385 (1986).","journal-title":"Journal of Neurosurgery"},{"key":"12603_CR68","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ceb.2008.01.002","volume":"20","author":"MF Olson","year":"2008","unstructured":"Olson, M. F. Applications for ROCK kinase inhibition. Curr Opin Cell Biol \n                           20, 242\u2013248 (2008).","journal-title":"Curr Opin Cell Biol"},{"key":"12603_CR69","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2176\/nmc.48.241","volume":"48","author":"Y Suzuki","year":"2008","unstructured":"Suzuki, Y. et al. Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study. Neurol Med Chir (Tokyo) \n                           48, 241\u2013248 (2008).","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"12603_CR70","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1161\/hc1002.105938","volume":"105","author":"A Masumoto","year":"2002","unstructured":"Masumoto, A. et al. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation \n                           105, 1545\u20131547 (2002).","journal-title":"Circulation"},{"key":"12603_CR71","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.wneu.2011.02.030","volume":"6","author":"GJ Velat","year":"2011","unstructured":"Velat, G. J., Kimball, M. M., Mocco, J. D. & Hoh, B. L. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature. World Neurosurg \n                           6, 446\u2013454 (2011).","journal-title":"World Neurosurg"},{"key":"12603_CR72","doi-asserted-by":"publisher","first-page":"8291","DOI":"10.1038\/sj.onc.1208993","volume":"24","author":"S Bharadwaj","year":"2005","unstructured":"Bharadwaj, S., Thanawala, R., Bon, G., Falcioni, R. & Prasad, G. L. Resensitization of breast cancer cells to anoikis by tropomyosin-1: role of Rho kinase-dependent cytoskeleton and adhesion. Oncogene \n                           24, 8291\u20138303, https:\/\/doi.org\/10.1038\/sj.onc.1208993 (2005).","journal-title":"Oncogene"},{"key":"12603_CR73","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.neo.2016.07.002","volume":"18","author":"I Hinsenkamp","year":"2016","unstructured":"Hinsenkamp, I. et al. Inhibition of rho-associated kinase 1\/2 attenuates tumor growth in murine gastric cancer. Neoplasia \n                           18, 500\u2013511, https:\/\/doi.org\/10.1016\/j.neo.2016.07.002 (2016).","journal-title":"Neoplasia"},{"key":"12603_CR74","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/nbt.2017","volume":"29","author":"T Anastassiadis","year":"2011","unstructured":"Anastassiadis, T., Deacon, S. W., Devarajan, K., Ma, H. & Peterson, J. R. Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat. Biotechnol. \n                           29, 1039\u20131045 (2011).","journal-title":"Nat. Biotechnol."},{"key":"12603_CR75","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1093\/hmg\/10.19.2123","volume":"10","author":"K Luiro","year":"2001","unstructured":"Luiro, K., K., O., Lehtovirta, M. & Jalanko, A. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease. Hum Mol Genet. \n                           10, 2123\u20132131 (2001).","journal-title":"Hum Mol Genet."},{"key":"12603_CR76","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/jnr.20367","volume":"79","author":"SN Phillips","year":"2005","unstructured":"Phillips, S. N., Benedict, J. W., Weimer, J. M. & Pearce, D. A. CLN3, the protein associated with batten disease: structure, function and localization. Journal of neuroscience research \n                           79, 573\u2013583, https:\/\/doi.org\/10.1002\/jnr.20367 (2005).","journal-title":"Journal of neuroscience research"},{"key":"12603_CR77","first-page":"2375","volume":"38","author":"ML Katz","year":"1997","unstructured":"Katz, M. L. et al. Immunochemical localization of the Batten disease (CLN3) protein in retina. Investigative Ophthalmology & Visual Science \n                           38, 2375\u20132386 (1997).","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"12603_CR78","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.nbd.2017.03.015","volume":"103","author":"A Mohammed","year":"2017","unstructured":"Mohammed, A., O\u2019Hare, M. B., Warley, A., Tear, G. & Tuxworth, R. I. in vivo localization of the neuronal ceroid lipofuscinosis proteins, CLN3 and CLN7, at endogenous expression levels. Neurobiology of disease \n                           103, 123\u2013132, https:\/\/doi.org\/10.1016\/j.nbd.2017.03.015 (2017).","journal-title":"Neurobiology of disease"},{"key":"12603_CR79","doi-asserted-by":"publisher","first-page":"18065","DOI":"10.1523\/JNEUROSCI.0498-13.2013","volume":"33","author":"L Tecedor","year":"2013","unstructured":"Tecedor, L. et al. CLN3 Loss Disturbs Membrane Microdomain Properties and Protein Transport in Brain Endothelial Cells. The Journal of Neuroscience \n                           33, 18065\u201318079, https:\/\/doi.org\/10.1523\/JNEUROSCI.0498-13.2013 (2013).","journal-title":"The Journal of Neuroscience"},{"key":"12603_CR80","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/hmg\/ddr088","volume":"20","author":"RI Tuxworth","year":"2011","unstructured":"Tuxworth, R. I. et al. The Batten disease gene CLN3 is required for the response to oxidative stress. Human molecular genetics \n                           20, 2037\u20132047, https:\/\/doi.org\/10.1093\/hmg\/ddr088 (2011).","journal-title":"Human molecular genetics"},{"key":"12603_CR81","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1086\/504159","volume":"78","author":"R Steinfeld","year":"2006","unstructured":"Steinfeld, R. et al. Cathepsin D Deficiency Is Associated with a Human Neurodegenerative Disorder. The American Journal of Human Genetics \n                           78, 988\u2013998, https:\/\/doi.org\/10.1086\/504159 (2006).","journal-title":"The American Journal of Human Genetics"},{"key":"12603_CR82","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1096\/fasebj.5.3.2001789","volume":"5","author":"JS O\u2019Brien","year":"1991","unstructured":"O\u2019Brien, J. S. & Kishimoto, Y. Saposin proteins: structure, function, and role in human lysosomal storage disorders. FASEB J. \n                           5, 301\u2013308 (1991).","journal-title":"FASEB J."},{"key":"12603_CR83","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0014-5793(93)80908-D","volume":"330","author":"J Tyynel\u00e4","year":"1993","unstructured":"Tyynel\u00e4, J., Palmer, D. N., Baumann, M. & Haltia, M. Storage of saposins A and D in infantile neuronal ceroid-lipofuscinosis. FEBS Letters \n                           330, 8\u201312, https:\/\/doi.org\/10.1016\/0014-5793(93)80908-D (1993).","journal-title":"FEBS Letters"},{"key":"12603_CR84","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1126\/science.178.4065.1100","volume":"178","author":"M Sugita","year":"1972","unstructured":"Sugita, M., Dulaney, J. T. & Moser, H. W. Ceramidase Deficiency in Farber\u2019s Disease (Lipogranulomatosis). Science \n                           178, 1100\u20131102, https:\/\/doi.org\/10.1126\/science.178.4065.1100 (1972).","journal-title":"Science"},{"key":"12603_CR85","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ymgme.2015.06.008","volume":"115","author":"H Peters","year":"2015","unstructured":"Peters, H. et al. Metabolite studies in HIBCH and ECHS1 defects: Implications for screening. Molecular genetics and metabolism \n                           115, 168\u2013173, https:\/\/doi.org\/10.1016\/j.ymgme.2015.06.008 (2015).","journal-title":"Molecular genetics and metabolism"},{"key":"12603_CR86","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ymgme.2015.05.008","volume":"115","author":"AR Stiles","year":"2015","unstructured":"Stiles, A. R. et al. Successful diagnosis of HIBCH deficiency from exome sequencing and positive retrospective analysis of newborn screening cards in two siblings presenting with Leigh\u2019s disease. Molecular genetics and metabolism \n                           115, 161\u2013167, https:\/\/doi.org\/10.1016\/j.ymgme.2015.05.008 (2015).","journal-title":"Molecular genetics and metabolism"},{"key":"12603_CR87","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1093\/hmg\/11.22.2709","volume":"11","author":"SL Cotman","year":"2002","unstructured":"Cotman, S. L. et al. Cln3(Deltaex7\/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth. Hum Mol Genet. \n                           11, 2709\u20132721 (2002).","journal-title":"Hum Mol Genet."},{"key":"12603_CR88","doi-asserted-by":"publisher","first-page":"13566","DOI":"10.1073\/pnas.251485198","volume":"98","author":"P Gupta","year":"2001","unstructured":"Gupta, P. et al. Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proc. Natl Acad. Sci. USA \n                           98, 13566\u201313571 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"12603_CR89","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.nbd.2012.04.018","volume":"47","author":"M Bible","year":"2012","unstructured":"Bible, M., Lehesjoki, A. E., Jalanko, A., Cooper, J. D. & Kopra, O. Selective spatiotemporal patterns of glial activation and neuron loss in the sensory thalamocortical pathways of neuronal ceroid lipofuscinosis 8 mice. Neurobiol. Dis. \n                           47, 444\u2013457 (2012).","journal-title":"Neurobiol. Dis."},{"key":"12603_CR90","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/NEN.0b013e31823e68e1","volume":"71","author":"S Tegelberg","year":"2012","unstructured":"Tegelberg, S., Kopra, O., Joensuu, T., Cooper, J. D. & Lehesjoki, A. E. Early microglial activation precedes neuronal loss in the brain of the cstb\u2212\/\u2212 mouse model of progressive myoclonus epilepsy, EPM1. J. Neuropathol. Exp. Neurol \n                           71, 40\u201353 (2012).","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"12603_CR91","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1093\/hmg\/ddq340","volume":"19","author":"TM Wishart","year":"2010","unstructured":"Wishart, T. M. et al. SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy. Human molecular genetics \n                           19, 4216\u20134228, https:\/\/doi.org\/10.1093\/hmg\/ddq340 (2010).","journal-title":"Human molecular genetics"},{"key":"12603_CR92","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1074\/mcp.M600457-MCP200","volume":"6","author":"TM Wishart","year":"2007","unstructured":"Wishart, T. M. et al. Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene. Mol Cell Proteomics \n                           6, 1318\u20131330 (2007).","journal-title":"Mol Cell Proteomics"},{"key":"12603_CR93","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1021\/pr1005263","volume":"9","author":"HR Fuller","year":"2010","unstructured":"Fuller, H. R. et al. Valproate and bone loss: iTRAQ proteomics show that valproate reduces collagens and osteonectin in SMA cells. J Proteome Res. \n                           9, 4228\u20134233 (2010).","journal-title":"J Proteome Res."},{"key":"12603_CR94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072457","volume":"8","author":"SL Eaton","year":"2013","unstructured":"Eaton, S. L. et al. Total protein analysis as a reliable loading control for quantitative fluorescent Western blotting. PLoS One \n                           8, e72457 (2013).","journal-title":"PLoS One"},{"key":"12603_CR95","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1074\/mcp.M115.054635","volume":"14","author":"BC McGorum","year":"2015","unstructured":"McGorum, B. C. et al. Proteomic Profiling of Cranial (Superior) Cervical Ganglia Reveals Beta-Amyloid and Ubiquitin Proteasome System Perturbations in an Equine Multiple System Neuropathy. Mol Cell Proteomics \n                           14, 3072\u20133086, https:\/\/doi.org\/10.1074\/mcp.M115.054635 (2015).","journal-title":"Mol Cell Proteomics"},{"key":"12603_CR96","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc. \n                           4, 44\u201357 (2009).","journal-title":"Nature Protoc."},{"key":"12603_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. \n                           37, 1\u201313 (2009).","journal-title":"Nucleic Acids Res."},{"key":"12603_CR98","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1242\/jcs.194241","volume":"130","author":"IS Amorim","year":"2017","unstructured":"Amorim, I. S. et al. Sideroflexin 3 is an \u03b1-synuclein-dependent mitochondrial protein that regulates synaptic morphology. Journal of Cell Science \n                           130, 325\u2013331, https:\/\/doi.org\/10.1242\/jcs.194241 (2017).","journal-title":"Journal of Cell Science"},{"key":"12603_CR99","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3858\/emm.2008.40.2.176","volume":"40","author":"H Savli","year":"2008","unstructured":"Savli, H., Szendr\u00f6i, A., Romics, I. & Nagy, B. Gene network and canonical pathway analysis in prostate cancer: a microarray study. Exp Mol Med. \n                           40, 176\u2013185 (2008).","journal-title":"Exp Mol Med."},{"key":"12603_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-357","volume":"12","author":"Y Hu","year":"2011","unstructured":"Hu, Y. et al. An integrative approach to ortholog prediction for disease-focused and other functional studies. BMC Bioinformatics \n                           12, 357 (2011).","journal-title":"BMC Bioinformatics"},{"key":"12603_CR101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005107","volume":"11","author":"M Sanhueza","year":"2015","unstructured":"Sanhueza, M. et al. Network analyses reveal novel aspects of ALS pathogenesis. PLoS genetics \n                           11, e1005107, https:\/\/doi.org\/10.1371\/journal.pgen.1005107 (2015).","journal-title":"PLoS genetics"},{"key":"12603_CR102","doi-asserted-by":"crossref","unstructured":"Verspoor, R. L., Heys, C. & Price, T. A. Dyeing Insects for Behavioral Assays: the Mating Behavior of Anesthetized. J Vis Exp. 98 (2015).","DOI":"10.3791\/52645"},{"key":"12603_CR103","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.nbd.2004.02.010","volume":"16","author":"E Bible","year":"2004","unstructured":"Bible, E., Gupta, P., Hofmann, S. L. & Cooper, J. D. Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis. Neurobiol. Dis. \n                           16, 346\u2013359 (2004).","journal-title":"Neurobiol. Dis."},{"key":"12603_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/gm498","volume":"5","author":"CA Mutsaers","year":"2013","unstructured":"Mutsaers, C. A., Lamont, D. J., Hunter, G., Wishart, T. M. & Gillingwater, T. H. Label-free proteomics identifies Calreticulin and GRP75\/Mortalin as peripherally accessible protein biomarkers for spinal muscular atrophy. Genome Med. \n                           5, 95 (2013).","journal-title":"Genome Med."},{"key":"12603_CR105","unstructured":"R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria (2008)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12603-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12603-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12603-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:31:12Z","timestamp":1671795072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12603-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,29]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["12603"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-12603-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,29]]},"assertion":[{"value":"9 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12412"}}